BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 2736721)

  • 1. Transcription-terminating lesions induced by bifunctional alkylating agents in vitro.
    Pieper RO; Futscher BW; Erickson LC
    Carcinogenesis; 1989 Jul; 10(7):1307-14. PubMed ID: 2736721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA adenine adducts induced by nitrogen mustards and their role in transcription termination in vitro.
    Pieper RO; Erickson LC
    Carcinogenesis; 1990 Oct; 11(10):1739-46. PubMed ID: 2208589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nitrogen mustard inhibits transcription and translation in a cell free system.
    Masta A; Gray PJ; Phillips DR
    Nucleic Acids Res; 1995 Sep; 23(17):3508-15. PubMed ID: 7567463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thermolabile adenine adducts and A.T base pair substitutions induced by nitrogen mustard analogues in an SV40-based shuttle plasmid.
    Wang P; Bauer GB; Bennett RA; Povirk LF
    Biochemistry; 1991 Dec; 30(49):11515-21. PubMed ID: 1660721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA damage and mutagenesis induced by nitrogen mustards.
    Povirk LF; Shuker DE
    Mutat Res; 1994 Dec; 318(3):205-26. PubMed ID: 7527485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA sequence selectivity of guanine-N7 alkylation by nitrogen mustards.
    Mattes WB; Hartley JA; Kohn KW
    Nucleic Acids Res; 1986 Apr; 14(7):2971-87. PubMed ID: 3960738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA sequence selectivity of guanine-N7 alkylation by nitrogen mustards is preserved in intact cells.
    Hartley JA; Bingham JP; Souhami RL
    Nucleic Acids Res; 1992 Jun; 20(12):3175-8. PubMed ID: 1620613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro transcription analysis of DNA alkylation by nitrogen mustard.
    Gray PJ; Cullinane C; Phillips DR
    Biochemistry; 1991 Aug; 30(32):8036-40. PubMed ID: 1868077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA-damaging and transcription-terminating lesions induced by AF64A in vitro.
    Futscher BW; Pieper RO; Barnes DM; Hanin I; Erickson LC
    J Neurochem; 1992 Apr; 58(4):1504-9. PubMed ID: 1548483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of alkylating agents on initiation and elongation of the lac UV5 promoter.
    Gray PJ; Phillips DR
    Biochemistry; 1993 Nov; 32(46):12471-7. PubMed ID: 8241138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Excision of DNA adducts of nitrogen mustards by bacterial and mammalian 3-methyladenine-DNA glycosylases.
    Mattes WB; Lee CS; Laval J; O'Connor TR
    Carcinogenesis; 1996 Apr; 17(4):643-8. PubMed ID: 8625472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anomalous cross-linking by mechlorethamine of DNA duplexes containing C-C mismatch pairs.
    Romero RM; Mitas M; Haworth IS
    Biochemistry; 1999 Mar; 38(12):3641-8. PubMed ID: 10090751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA sequence-specific adenine alkylation by the novel antitumor drug tallimustine (FCE 24517), a benzoyl nitrogen mustard derivative of distamycin.
    Broggini M; Coley HM; Mongelli N; Pesenti E; Wyatt MD; Hartley JA; D'Incalci M
    Nucleic Acids Res; 1995 Jan; 23(1):81-7. PubMed ID: 7870593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in c-myc and c-fos expression in a human tumor cell line following exposure to bifunctional alkylating agents.
    Futscher BW; Erickson LC
    Cancer Res; 1990 Jan; 50(1):62-6. PubMed ID: 2104539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sequence specificity of alkylation for a series of nitrogen mustard-containing analogues of distamycin of increasing binding site size: evidence for increased cytotoxicity with enhanced sequence specificity.
    Wyatt MD; Lee M; Garbiras BJ; Souhami RL; Hartley JA
    Biochemistry; 1995 Oct; 34(40):13034-41. PubMed ID: 7548062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alkylating agent and chromatin structure determine sequence context-dependent formation of alkylpurines.
    Cloutier JF; Castonguay A; O'Connor TR; Drouin R
    J Mol Biol; 2001 Feb; 306(2):169-88. PubMed ID: 11237592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the Lonidamine Potentiated Effect of Nitrogen Mustard Alkylating Agents on the Systemic Treatment of DB-1 Human Melanoma Xenografts in Mice.
    Nath K; Nelson DS; Putt ME; Leeper DB; Garman B; Nathanson KL; Glickson JD
    PLoS One; 2016; 11(6):e0157125. PubMed ID: 27285585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA-directed alkylating ligands as potential antitumor agents: sequence specificity of alkylation by intercalating aniline mustards.
    Prakash AS; Denny WA; Gourdie TA; Valu KK; Woodgate PD; Wakelin LP
    Biochemistry; 1990 Oct; 29(42):9799-807. PubMed ID: 2271617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA sequence selectivity of guanine-N7 alkylation by three antitumor chloroethylating agents.
    Hartley JA; Gibson NW; Kohn KW; Mattes WB
    Cancer Res; 1986 Apr; 46(4 Pt 2):1943-7. PubMed ID: 3004713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibody recognition of melphalan adducts characterized using immobilized DNA: enhanced alkylation of G-Rich regions in cells compared to in vitro.
    McCartney H; Martin AM; Middleton PG; Tilby MJ
    Chem Res Toxicol; 2001 Jan; 14(1):71-81. PubMed ID: 11170510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.